tiprankstipranks
Advertisement
Advertisement

SER Stock Latest News

Serina Therapeutics Amends CEO Employment and Compensation Terms
Company AnnouncementsSerina Therapeutics Amends CEO Employment and Compensation Terms
1d ago
8K
SER
Serina Therapeutics completes enrollment and dosing in Parkinson’s trial
PremiumThe Fly
Serina Therapeutics completes enrollment and dosing in Parkinson’s trial
1d ago
SER
Serina Therapeutics Adds Industry Veteran to Board
PremiumCompany Announcements
Serina Therapeutics Adds Industry Veteran to Board
2d ago
8K
SER
Serina Therapeutics appoints Trevi Therapeutics CCO Farrell Simon to board
PremiumThe Fly
Serina Therapeutics appoints Trevi Therapeutics CCO Farrell Simon to board
2d ago
SER
TRVI
Serina completes sentinel dosing in Cohort 1 of Phase 1b trial of SER-252
PremiumThe Fly
Serina completes sentinel dosing in Cohort 1 of Phase 1b trial of SER-252
15d ago
SER
Serina Therapeutics initiated with a Buy at BTIG
PremiumThe FlySerina Therapeutics initiated with a Buy at BTIG
24d ago
SER
Serina Therapeutics Shareholders Approve Expanded Equity and Governance
Premium
Company Announcements
Serina Therapeutics Shareholders Approve Expanded Equity and Governance
1M ago
8K
SER
Serina Therapeutics files to sell 16.45M shares of common stock for holders
Premium
The Fly
Serina Therapeutics files to sell 16.45M shares of common stock for holders
2M ago
SER
Insider-Backed PIPE Deal May Dilute Serina Therapeutics Shareholders and Heighten Governance Risks
PremiumCompany Announcements
Insider-Backed PIPE Deal May Dilute Serina Therapeutics Shareholders and Heighten Governance Risks
2M ago
SER
Serina Therapeutics Updates Executive Leadership and Governance Structure
PremiumCompany Announcements
Serina Therapeutics Updates Executive Leadership and Governance Structure
3M ago
8K
SER
Serina Therapeutics announces NYSE acceptance of plan to regain compliance
PremiumThe Fly
Serina Therapeutics announces NYSE acceptance of plan to regain compliance
4M ago
SER
Serina Therapeutics Announces Premium Private Placement Financing
PremiumCompany Announcements
Serina Therapeutics Announces Premium Private Placement Financing
4M ago
8K
SER
Nasus Pharma’s NS002 Demonstrates Consistent Early Advantage in Epinephrine Delivery (NYSE: NSRX)
PremiumTipRanks NewswireNasus Pharma’s NS002 Demonstrates Consistent Early Advantage in Epinephrine Delivery (NYSE: NSRX)
4M ago
SER
NSRX
Serina Therapeutics names Greg Bailey co-chairman
Premium
The Fly
Serina Therapeutics names Greg Bailey co-chairman
4M ago
SER
Serina Therapeutics Advances SER-252 Parkinson’s Trial, Marking a Key Early Milestone for Investors
Premium
Company Announcements
Serina Therapeutics Advances SER-252 Parkinson’s Trial, Marking a Key Early Milestone for Investors
5M ago
SER
Serina Therapeutics doses first patient in SER-252 trial
PremiumThe Fly
Serina Therapeutics doses first patient in SER-252 trial
5M ago
SER
Serina Therapeutics says first patient enrolled in Phase 1b trial of SER-252
PremiumThe Fly
Serina Therapeutics says first patient enrolled in Phase 1b trial of SER-252
5M ago
SER
Serina Therapeutics files to sell 7.72M shares of common stock for holders
PremiumThe Fly
Serina Therapeutics files to sell 7.72M shares of common stock for holders
6M ago
SER
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
6M ago
BX
MP
This Is Why Serina Therapeutics Stock (SER) Rocketed Today
PremiumMarket NewsThis Is Why Serina Therapeutics Stock (SER) Rocketed Today
6M ago
SER
Serina Therapeutics announces FDA clearance of SER-252 new drug application
Premium
The Fly
Serina Therapeutics announces FDA clearance of SER-252 new drug application
6M ago
SER
Serina Therapeutics receives NYSE deficiency notice on equity standards
Premium
The Fly
Serina Therapeutics receives NYSE deficiency notice on equity standards
6M ago
SER

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >